The two cohorts' top 100 differentially expressed genes (based on survival status) were compared, revealing that ANO1 and SQLE are the two genes commonly differentially expressed between those TAZ-AXL-CTGF-high colon cancer patients who are still alive and those who are deceased. This evidence concerns the gene CCN2 and malignant colon neoplasm.